Hyperfine has appointed Roots Pharmaceutical Co. W.L.L. as the exclusive distributor of its Swoop® portable brain MRI system in Kuwait and the UAE.
Under the agreement, Roots Pharmaceutical will support regulatory activities, product education, demonstrations, customer engagement and, following required approvals, commercial and service activities.
The partnership is part of Hyperfine’s international expansion strategy and aims to improve access to advanced brain imaging technology across the GCC.
Also read: FDA Approves Olumiant for Adolescents with Severe Alopecia Areata
“Expanding into new countries is one of the growth vectors for our international business at Hyperfine, and we are excited to partner with Roots Pharmaceutical to support the introduction and drive the future adoption of the Swoop system across these markets,” said Eric Willis, Vice President, International at Hyperfine. “Roots brings strong customer relationships and a deep understanding of the healthcare landscape throughout the Gulf Cooperation Council (GCC) Region. Together, we look forward to supporting clinicians and healthcare institutions as they seek new ways to deliver high-quality imaging closer to the patient.”
The Swoop system is an AI-powered portable MRI technology designed for brain imaging and can bring diagnostic imaging closer to patients in different healthcare settings. It may support clinical assessment of conditions including stroke and neurodegenerative diseases.
“We are honored to be selected as Hyperfine’s distribution partner for Kuwait and the UAE,” said Islam Zayed, Chief Executive Officer of Roots Pharmaceutical. “The Swoop system represents a significant advancement in diagnostic brain imaging and aligns closely with our mission of bringing innovative healthcare solutions to the region. We believe this portable brain MRI technology can help hospitals improve access to critical diagnostic information while supporting better patient care across a variety of clinical settings.”
Click here to join our WhatsApp channel here
Roots Pharmaceutical will work with Hyperfine to introduce the technology to healthcare providers in Kuwait and the UAE, subject to applicable regulatory clearances.
